maleimide has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filippov, SK; Kaldybekov, DB; Khutoryanskiy, VV; Radulescu, A | 1 |
| Belgorosky, D; Bérubé, G; Cloutier, S; Eiján, AM; Girouard, J; Hamelin-Morrissette, J; Legault, J; Reyes-Moreno, C | 1 |
2 other study(ies) available for maleimide and Bladder Cancer
| Article | Year |
|---|---|
Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
Topics: Animals; Drug Carriers; Drug Compounding; Drug Delivery Systems; Maleimides; Molecular Weight; Mucous Membrane; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Sheep; Urinary Bladder; Urinary Bladder Neoplasms | 2019 |
Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carboxylic Acids; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Macrophages; Maleimides; Mice; Molecular Structure; Nitric Oxide; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2015 |